vorinostat has been researched along with Rheumatoid Arthritis in 5 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Furthermore, compared with SAHA, MPT0G009 exhibited longer half-life (9." | 1.40 | Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009. ( Hsieh, IN; Lai, MJ; Lee, HY; Li, YH; Liou, JP; Yang, CR, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DS | 1 |
| Min, HK | 1 |
| Kim, EK | 1 |
| Yang, SC | 1 |
| Na, HS | 1 |
| Lee, SY | 1 |
| Choi, JW | 1 |
| Jung, KA | 1 |
| Kwok, SK | 1 |
| Park, SH | 1 |
| Cho, ML | 1 |
| Hsieh, IN | 1 |
| Liou, JP | 1 |
| Lee, HY | 1 |
| Lai, MJ | 1 |
| Li, YH | 1 |
| Yang, CR | 1 |
| Chen, H | 1 |
| Pan, J | 1 |
| Wang, JD | 1 |
| Liao, QM | 1 |
| Xia, XR | 1 |
| Choo, QY | 1 |
| Ho, PC | 1 |
| Tanaka, Y | 1 |
| Lin, HS | 2 |
| Hu, CY | 1 |
| Chan, HY | 1 |
| Liew, YY | 1 |
| Huang, HP | 1 |
| Lepescheux, L | 1 |
| Bastianelli, E | 1 |
| Baron, R | 1 |
| Rawadi, G | 1 |
| Clément-Lacroix, P | 1 |
5 other studies available for vorinostat and Rheumatoid Arthritis
| Article | Year |
|---|---|
Suberoylanilide Hydroxamic Acid Attenuates Autoimmune Arthritis by Suppressing Th17 Cells through NR1D1 Inhibition.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; | 2019 |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009.
Topics: Acetylation; Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthr | 2014 |
Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
Topics: Acetylcysteine; Apoptosis; Arthritis, Rheumatoid; bcl-X Protein; Caspase 3; Cell Survival; Cells, Cu | 2016 |
Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells.
Topics: Animals; Arthritis, Rheumatoid; Benzamides; Cells, Cultured; Cytokines; Down-Regulation; Fibroblasts | 2010 |
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Benzamides; Female; H | 2007 |